UNPLUG 0.31

UNPLUG 0.31 contain Levosalbutamol, a selective beta-2 adrenergic bronchodilator that helps improve airflow by relaxing the muscles surrounding the airways. This action supports easier breathing and helps reduce symptoms caused by bronchospasm, such as wheezing, chest tightness, and shortness of breath.

The medication is administered through a nebulizer, allowing direct delivery into the lungs for targeted respiratory therapy. Nebulization may be particularly beneficial for patients who find it difficult to coordinate inhaler use, including young children, elderly individuals, and those requiring assisted respiratory care.

When used according to medical advice, UNPLUG 0.31 help support better respiratory function and may contribute to improved daily breathing comfort.

Indications / Uses

UNPLUG 0.31 are indicated for the management of respiratory conditions associated with bronchospasm and reversible airway obstruction. The medication helps widen the airways and supports improved airflow, making breathing easier during episodes of airway narrowing.

The treatment may be prescribed to help reduce symptoms including wheezing, coughing, breathlessness, and chest tightness. Nebulized administration provides effective medication delivery directly to the lungs, supporting respiratory care in patients requiring nebulization therapy.

Regular use should always be based on the advice of a qualified healthcare professional.

How It Works

NPLUG 0.31 contain Levosalbutamol, which selectively stimulates beta-2 receptors present in the smooth muscles of the airways. Activation of these receptors relaxes the airway muscles, allowing the air passages to widen and improving airflow into and out of the lungs.

As breathing becomes easier, symptoms such as wheezing, chest tightness, and breathlessness may be relieved. Because the medication is delivered directly through nebulization, it reaches the lungs efficiently and begins acting at the site where respiratory support is required.

Benefits

UNPLUG 0.31 help provide effective bronchodilation by relaxing the airway muscles and improving airflow. Regular use as prescribed may help reduce breathing discomfort and support better lung function.

The nebulized formulation offers targeted medication delivery, making it suitable for patients who require nebulizer therapy or experience difficulty using handheld inhalers. The treatment may also help improve daily activity levels by supporting comfortable breathing and reducing episodes of airway narrowing.

With consistent use under medical supervision, UNPLUG 0.31 contribute to effective respiratory management and improved quality of life.

Dosage & Administration

UNPLUG 0.31 should be used only as directed by a qualified healthcare professional. The dosage and frequency depend on the patient’s age, respiratory condition, and clinical response.

Open the respule carefully and transfer the prescribed quantity into the nebulizer chamber. Inhale the generated mist through a face mask or mouthpiece until the nebulization process is complete.

The nebulizer should be cleaned thoroughly after every use to maintain hygiene and ensure effective medication delivery. Patients should follow the prescribed treatment schedule without altering the dosage unless advised by their healthcare provider.

Precautions & Warnings

Before using UNPLUG 0.31, patients should inform their healthcare provider about any existing medical conditions, especially heart disease, hypertension, diabetes, thyroid disorders, seizures, or known allergies to Levosalbutamol or similar medications.

The medication should be used only under medical supervision, particularly in children and elderly patients. Patients experiencing worsening respiratory symptoms despite treatment should seek prompt medical attention.

Pregnant or breastfeeding women should consult their healthcare provider before beginning therapy.

Side Effects

Like all medications, UNPLUG 0.31 may cause side effects in some individuals, although many patients tolerate the medication well.

Common side effects may include mild tremors, headache, nervousness, throat irritation, cough, dizziness, dry mouth, or a temporary increase in heart rate.

Rare but serious side effects such as allergic reactions, chest pain, severe palpitations, or worsening breathing difficulties require immediate medical attention.

Drug Interactions

Patients should inform their healthcare provider about all medicines they are currently taking, including prescription medications, herbal supplements, and over-the-counter products.

Interactions may occur with beta-blockers, diuretics, corticosteroids, certain antidepressants, or other bronchodilator medications, which may affect treatment response or increase the likelihood of side effects.

Patients should never begin or discontinue any medication without professional medical advice during treatment with UNPLUG 0.31.

Storage Instructions

Store UNPLUG 0.31 in their original packaging in a cool, dry place below 25°C, protected from direct sunlight, heat, and moisture.

Keep the respules sealed until they are ready for use. Do not freeze the solution. Discard damaged, leaking, or expired respules appropriately.

Keep the medication out of the reach of children and pets.

Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult a qualified healthcare professional before using any medication.